Several regulatory bodies have agreed that low-dose radiation used in medical imaging is a weak carcinogen that follows a linear, nonthreshold model of cancer risk. While avoiding radiation is the best course of action to mitigate risk, computed tomography (CT) scans are often critical for diagnosis. In addition to the as low as reasonably achievable principle, a more concrete method of dose reduction for common CT imaging exams is the use of a diagnostic reference level (DRL). This paper examines Canada's national DRL values from the recent CT survey and compares it to published provincial DRLs as well as the DRLs in the United Kingdom and the United States of America for the 3 most common CT exams: head, chest, and abdomen/pelvis. Canada compares well on the international scale, but it should consider using more electronic dose monitoring solutions to create a culture of dose optimization.
Radiation is known to be a weak carcinogen [1] . Many regulatory bodies, such as the International Atomic Energy Agency [2] , the Committee on the Biologic Effects of Ionizing Radiation [3] , the United Nations Scientific Committee on the Effects of Atomic Radiation [4] , and the International Committee on Radiological Protection [5] recommend that the linear, non-threshold model be used when modelling a patient's cancer risk from ionizing radiation, as derived from the Life Span Study of atomic bomb survivors [6] . The linear, non-threshold model suggests that with each exposure to ionizing radiation, a patient's risk of stochastic effects increases linearly. Therefore, the only way to mitigate the risk associated with medical imaging is to avoid any imaging exposure. Unfortunately, this proves impossible in many cases.
Introduced by the ICRP, the as low as reasonably achievable (ALARA) principle is used to provide a guideline when using ionizing radiation for imaging to minimize stochastic and deterministic effects associated with imaging as the effects are less likely with lower dose [1] . Radiation dose monitoring would allow for clinicians, physicists, technologists, and other health care professionals to ensure that the ALARA principle is adhered to throughout the diagnostic imaging process [7] . This would be done by ensuring doses are at or below a diagnostic reference level (DRL) [8] .
A DRL is a level that can help guide computed tomography (CT) practice. The Institute of Physics and Engineering in Medicine explains that for a specific scan or population (ie, body part versus paediatric/adult), DRLs can be set by using the third quartile dose-length product (DLP) (75th percentile) to identify exams that are above the median level [9] . The mean value (50th percentile) is considered an achievable value, but the 75th percentile is a good starting point [10] . It is important to remember that the DRL is not an optimal level; it is a level that can be used to identify unusual practice and set a standard of care [10] . The DRL should be revisited to drive doses lower when new technology is obtained or to ensure that technologists are indeed lowering doses.
Using the 2016 Health Canada Canadian Computed Tomography Dose Survey (referred to as HC13 because the final year of data collection was 2013) as motivation, an environmental scan was conducted to examine the state of diagnostic imaging radiation monitoring practices throughout Canada. New DRLs were established in Canada to better guide practice than the recommended DRL ranges in Safety Procedures for the Installation, Use, and Control of X-ray Equipment in Large Medical Radiological Facilities, also known as Safety Code 35 (SC35) [11] . The gap identified in the Health Canada survey is that there is no clear provincial breakdown or insight into what tools were used to gather the data. This environmental scan focuses on the top three most common CT scans in Canada, the abdomen/pelvis (47.4%), head/brain (27.3%), and chest (14.5%) [12] . The purpose of this literature review was to examine how well the provinces are performing comparing to the national DRLs for the head, chest, and abdomen/pelvis exams.
Methods
Using a Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) strategy, PubMed and MEDLINE databases were searched. The search was limited to include literature from 2007 to Current, published in the English language, and was conducted in a hospital environment. The search strategy used '*'Tomography, X-Ray Computed'/' and Radiation Dosage/and 'Canada'.mp. in MEDLINE. In PubMed, (('Radiation Dosage'[MAJR]) AND 'Tomography, X-Ray Computed/standards'[MAJR]) AND 'Canada' was used. Then, references were handexamined so as to see if any articles were missed, but none within the acceptable 2007-present timeline were found. Studies that only included paediatric CT scan DRLs were excluded for analysis. In summation, 8 articles from 6 provinces were deemed acceptable for inclusion in this environmental scan.
The 75th percentile provincial DRL data for head, chest, and abdomen-pelvis was obtained in the literature and compared to 2 main pieces of government-created standards: HC13 and SC35. While the goal was to solely include plain, single-phase studies with no contrast for consistency in comparisons, it was not possible. For any studies that included multiphase exams, they have been marked with a dagger symbol (y) in the figures. To allow for greater comparison, data from the United Kingdom (UK11) [13] and the United States of America (US14) [14] were included as well, due to their length (first published DRLs in 1991) and size (1,310,727 exams), respectively. The studies' gathering methods were verified to identify if the study used average sized patients that were comparable to those listed in HC13, meaning that the patient was 19 years of age or older and had a mass from 50-90 kg, and a minimum sample size of 10 patients [11, 15] . It was also explored if the study's data was gathered electronically or manually.
Results
DRLs were obtained for British Columbia [16] , Quebec [17, 18] , Saskatchewan [19, 20] , Nova Scotia [21] , Manitoba [22] , and Ontario [23] . HC13 includes data from all provinces, Yukon Territory, and Northwest Territories. At the time of HC13, Nunavut did not have a CT scanner [10, 24] . Redundant data (such as that from Saskatchewan and Quebec) was maintained to allow for visualization of any changes within the years. Furthermore, QC10 was a study that used only 2 hospitals' data [17] , while QC08 and QC14 were for the entirety of the province [18] . ON13's data was gathered from only one site at St. Michael's Hospital in Toronto [23] . This data was applied to be province-wide to allow for easier comparison.
Most studies fulfilled the aforementioned data gathering methods, except for ON13. ON13 was a retrospective audit and their system did not calculate the patient's weight. ON13 was the sole study that used an electronic solution described by Boos et al [25] to automatically manage dose record keeping. SK06, SK08, MB10, and BC13 recorded the information at the time of the scan, but QC10, ON10, QC14, and QC08 were completed retrospectively, as they extracted data from the picture archiving and communication system after the fact.
This current study appears to be the sole paper to aggregate all of this Canadian data. Table 1 outlines the all of the uncovered studies, including the location, year of data collection, and the year of publication. For each anatomical region, the national DRL from HC13 is plotted to easily identify which provinces are within the limits in Figures 1, 2 , and 3. Figure 1 demonstrates the provincial DRLs for a CT of the head. SC35 recommends an acceptable range of 930-1300 mGy$cm, while HC13 set the DRL at 1302 mGy$cm. Only 3 provincial resultsdBC13, MB10, and SK08dare above both the HC13 and SC35 guidelines. SK08 was well above the acceptable range at 1478 mGy$cm. The explanation for this is due to a change in protocol for higher-quality images, resulting in increased dose [20] . Furthermore, multiphase studies were included in this value. QC14 showed vast improvement over QC08 and QC10, while all values were within acceptable limits. ON13 demonstrated the lowest DRL and shows the value in consistently reassessing the DRL as in 2010 the DRL was 874 mGy$cm. As seen in Table 2 , UK11 was identified as 970 mGy$cm, while US14 stated 962 mGy$cm. ON13 was the sole site to be below these values. Figure 2 demonstrates the provincial DRLs for a CT of the chest. SC35 stated the acceptable DRL to be within the 580-650 mGy$cm range. HC13 set the DRL to be at 521 mGy$cm. As seen in Table 2 , UK11 had a higher DRL than HC13 at 610 mGy$cm. US14 was 545 mGy$cm, also higher than HC13. Majority of studies had data that was over the HC13 DRL, but only 2 studies were higher than the range in SC35. These 5 studies include BC13, SK06, SK10, MB10, and ON13 for a total of 4 provinces exceeding the guideline. MB10 shares that their data may be higher because there is no standardization in protocols, but cite their use of multidetector CT scanners to likely be the largest culprit of high doses [22] . SK08 showed improvement over SK06. QC14 has a lower DRL than QC08, but not lower than QC10. This is likely due to protocol standardization at the sites in QC08. QC10 was the lowest DRL at 345 mGy$cm, well below the lower limit of 580 mGy$cm set by SC35. Most studies were below the limit.
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Abdomen/Pelvis CT Figure 3 demonstrates the provincial DRLs for a CT of the abdomen/pelvis. SC35 stated that the acceptable range of the scan varies from 560-1100 mGy$cm. The reason why this range is so large is due to the wide variation in body habitus, especially in the abdominal region, and the various clinical indications requiring different protocols. This variation is echoed with HC13 of 874 mGy$cm, UK11 at 745 mGy$cm, and US14 at 1004 mGy$cm, as exhibited in Table 2 . The environmental scan showed that there were 3 studies that were over the DRLdSK06, SK08, and MB10. SK08 had a higher DRL than SK06, which is not a positive. However, in their paper, they noted a reduction in single-phase abdomenpelvis CT doses [20] . The values displayed here included both single and multi-phase scans. MB10 had the highest DRL and was the sole value to not fall within the SC35 range. Again, the authors state that the common use of multidetector scanners and unstandardized protocol yielded the higher than average dose.
Discussion
An environmental scan was conducted to evaluate Canada's current status with regards to its national and provincial DRLs. While Health Canada's guidelines were published in 2016, and all data collection periods were prior to that date, it remained a valuable exercise to compile the provinces' data to illustrate how much work is to be done. Overall, it appeared that majority of the DRLs were below the national guidelines, with some consistent outliers (MB10 and SK08). This is to serve as motivation to share what can be done. These doses are quite likely not the optimal doses but the current status and can thusly be improved, as done in the United Kingdom [13] .
DRLs are the third quartile and are an acceptable dose, but the achievable dose is at the halfway point. Through the use of dose management software as demonstrated by ON13 [23] , and endorsed by the Canadian Association of Radiologists Radiation Protection Working Group [7] , doses can be easily monitored to pinpoint doses that can be decreased. For a low-tech solution, a reference card with the doses from previous studies can be maintained at the console where the technologists work, and they can be encouraged to have doses either at or below the DRL listed [22] . While the software is an investment, persistent dose monitoring can permit optimal doses to be achieved much quicker. Furthermore, the software can identify if certain examinations result above average doses or if specific technologists are struggling with acceptable doses.
While the DRL is an achievable dose, there are sometimes circumstances which limit the success in achieving the optimal dose. There are specific protocols where dose may be increased, such as using thinner slices for optimal results in multiplanar reconstruction for lung screening [26, 27] . Multidetector CT scanners used to produce multiplanar reconstruction images use more dose compared to single detector scanners [28] . Consistent monitoring can assist in reaching a DRL reflective of the ALARA principle. New technology including iterative reconstruction algorithms including adaptive iterative reconstruction and model-based iterative reconstruction [29] , high detective quantum efficiency detectors [18] , noise reduction filters [30] , and automatic exposure control [30] can dramatically decrease the dose associated with an imaging exam and yield much more acceptable doses. Sites with better technology can have lower local DRLs, so long as they are used. Some sites equipped with iterative reconstruction fail to use it, subjecting patients to greater dose [16] . Lastly, practices such as proper patient positioning, protocol standardization, collimation, and bismuth shielding, among others, can result in decreased patient doses [18] .
Canada's DRL values are comparable to the United States and United Kingdom's standards as illustrated in Table 2 . While Canada was the lowest with its chest DRL, SC35 had ranges commencing at a lower value for both the head at 930 mGy$cm compared to 962 mGy$cm from US14, and abdomen/pelvis 560 mGy$cm compared to 745 mGy$cm from UK11. However, it has been suggested that the upperlimits in SC35 should be the maximum dose required to image the specific anatomy [16] . Thus, perhaps the head DRL should be lowered to 1300 mGy$cm. Small limitations do exist to this environmental scan, mostly due to data availability. As mentioned, all studies were published prior to publication of the DRLs in HC16, so no direct comparisons could be made to the current data as they were simply sharing the current status at the time without any strong guidelines other than SC35's range. Another limitation is that some multiphase studies were compared in this environmental scan, which may have skewed results.
The absence of standardization of study protocols proves especially difficult to monitor due to wide variance and inconsistency, even within the same health centre [17] . Supplying CT dose index (CTDI vol ) and DLP conversion factors would offer clarity in the DRL calculations and perhaps less variation between sites. Only 2 studies identified in this survey explicitly shared CTDI vol values [21, 23] . If this is not possible, protocol standardization is also beneficial. In addition, manual dose collection in some studies can be viewed as a method prone to error.
For further emphasis, the variances in protocols is a major limitation present in all studies, and thus, in this environmental survey as well. A suggestion to overcome the protocol variation is to use water-equivalent diameter (D w ) for better inter-scanner and inter-hospital comparison as it is far more accurate for patient dose measurements in comparison to patient height and weight or BMI [31] . Future studies should share D w values or, at minimum, the CTDI vol values to allow for improved dose comparison. D w would allow the standard 50-90 kg patient as described by Health Canada to be better compared.
Conclusion
This is the first known paper that aggregated all published provincial DRL information for comparison with the recent Health Canada national DRLs. Some provinces are lagging behind others when it comes to dose optimization. It is recommended that the published DRL values be revisited once dose reduction techniques are implemented. In comparison to other countries, Canada does appear to be performing well overall. Dose monitoring technologies can also be implemented to automate the process to prevent any manual errors. Furthermore, DRLs can be used at hospitals to identify technologists that are commonly above the set DRL. There is plenty of room for Canada to improve and succeed at optimizing its DRLs to limit patients' exposure.
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